# OnCo record magrolimab (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/magrolimab/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "magrolimab" ;
  schema:name "Magrolimab"@en ;
  schema:description "The first 'don't eat me' signal blocker. Gilead paid $4.9B for it; it was stopped in 2024 after trials showed more deaths, not fewer."@en ;
  schema:url <https://onco.cc/drugs/magrolimab/> ;
  schema:dateModified "2026-09-06"^^xsd:date ;
  schema:citation <https://www.gilead.com/news-and-press/press-room/press-releases/> ;
  onco:status "withdrawn" ;
  onco:tag "failure", "lesson:toxicity" ;
  onco:modality "Monoclonal antibody (anti-CD47)" ;
  onco:cancers <https://onco.cc/cancers/aml/> ;
  onco:technologies <https://onco.cc/technologies/monoclonal-antibody/>, <https://onco.cc/technologies/cd47-blockade/> ;
  onco:targets <https://onco.cc/targets/cd47/> ;
  onco:companies <https://onco.cc/companies/gilead/> ;
  onco:pathways <https://onco.cc/pathways/cd47-sirpa/> ;
  onco:trials <https://onco.cc/trials/nct04313881/>, <https://onco.cc/trials/nct05079230/>, <https://onco.cc/trials/nct04778397/> .